Free Trial
OTCMKTS:AMBBY

Ambu A/S 5/7/2025 Earnings Report

Ambu A/S logo
$15.25 -0.17 (-1.10%)
As of 07/9/2025 10:48 AM Eastern

Ambu A/S EPS Results

Actual EPS
$0.10
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Ambu A/S Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Ambu A/S Announcement Details

Quarter
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Ambu A/S' next earnings date is estimated for Friday, August 22, 2025, based on past reporting schedules.

Conference Call Resources

Ambu A/S Earnings Headlines

European Growth Stocks Insiders Are Investing In
Why Volatility Keeps Coming Back — And How I Trade It
Volatility isn’t the enemy — it’s the opportunity. While most traders panic during market swings, Jeff Clark uses a three-step method to target quick wins from VIX spikes and sudden price moves. It works in any market direction… and he’s showing how it works in a free video, available now.
3 Growth Stocks Insiders Own With Up To 39% Earnings Growth
See More Ambu A/S Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Ambu A/S? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Ambu A/S and other key companies, straight to your email.

About Ambu A/S

Ambu A/S (OTCMKTS:AMBBY) is a global medical device company specializing in the development, manufacture and distribution of single‐use endoscopy, anesthesia and patient monitoring solutions. Its core product portfolio includes single‐use bronchoscopes, duodenoscopes and cystoscopes designed to reduce the risk of cross‐contamination and lower total cost of ownership for hospitals and clinics. In addition to endoscopy, Ambu offers a range of products for anesthesia and resuscitation, such as face masks, laryngeal masks and intubation devices, along with diagnostic tools including electrocardiogram (ECG) electrodes and sleep diagnostics equipment.

Founded in 1937 in Denmark, Ambu has evolved from supplying reusable technical medical devices to pioneering disposable technologies that address infection control and workflow efficiency. Over the decades, the company has expanded its global footprint through strategic investments in research and development as well as targeted acquisitions. Ambu’s products are marketed in more than 100 countries across Europe, the Americas and the Asia‐Pacific region, supported by a network of subsidiaries and distribution partners that enable local customer service, training and technical support.

Headquartered in Ballerup, Denmark, Ambu employs a diverse workforce of research scientists, engineers and healthcare specialists dedicated to advancing patient safety and clinical performance. The company’s executive leadership team is led by CEO Peter Buhl Nielsen, under whose direction Ambu has intensified its focus on innovation in single‐use endoscopy and strengthened its competitive position through collaborations with healthcare providers. Ambu continues to invest in cutting‐edge technologies and sustainable manufacturing practices to address evolving healthcare needs and regulatory requirements worldwide.

View Ambu A/S Profile

More Earnings Resources from MarketBeat